​

Funding Round

Series A - Neurana Pharmaceuticals

Series A - Neurana Pharmaceuticals

Investment Firm

Overview

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

Announced Date

May 08, 2018

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Sofinnova Investments

Sofinnova Investments

Sofinnova Investments is a early_stage_venture and late_stage_venture and post_ipo and venture firm.

Participant Investors

5

Investor Name
Participant InvestorMagnaSci Ventures
Participant InvestorNew Leaf Venture Partners
Participant InvestorLongitude Capital
Participant InvestorSofinnova Investments
Participant InvestorH.I.G. BioHealth Partners

Round Details and Background

Neurana Pharmaceuticals raised $60000000 on 2018-05-08 in Series A

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 08, 2018
Series A - Neurana Pharmaceuticals
5-60.0M

Recent Activity

There is no recent news or activity for this profile.